| 注册
首页|期刊导航|中国感染控制杂志|西安市结核分枝杆菌耐药基线调查

西安市结核分枝杆菌耐药基线调查

李于于 曾令城 柳巍

中国感染控制杂志2016,Vol.15Issue(12):952-955,4.
中国感染控制杂志2016,Vol.15Issue(12):952-955,4.DOI:10.3969/j.issn.1671-9638.2016.12.014

西安市结核分枝杆菌耐药基线调查

Baseline survey on drug resistance of Mycobacterium tuberculosis in Xi’an city

李于于 1曾令城 1柳巍1

作者信息

  • 1. 西安市疾病预防控制中心,陕西 西安 710054
  • 折叠

摘要

Abstract

Objective To investigate the baseline condition of initial and acquired drug resistance in patients with pulmonary tuberculosis in Xi’an city,and provide a scientific basis for the prevention and control of drug-resistant tuberculosis.Methods Patients with positive Mycobacteriumtuberculosis(MT)culture and received initial treatment and re-treatment in tuberculosis clinics of 14 districts (counties)in Xi’an and Xi’an Chest Hospital in 2015 were in-cluded in the study,antimicrobial susceptibility testing of 4 kinds of first-line anti-tuberculosis drugs were per-formed.Results The overall drug resistance rate of MT in Xi’an city was 31 .9% ,multidrug resistance rate (MDR) was 7.0% . Drug resistance rate and MDR in initial treatment group were 27.3% and 3.5% respectively,in re-treatment group were 59.5% and 28.6% respectively,drug resistance rate and MDR in re-treatment group were both higher than initial treatment group (both P<0.001).Conclusion The overall drug resistance rate of pulmona-ry tuberculosis patients in Xi’an city is lower than the whole nation,but MDR is slightly higher than the national level,although TB prevention and control work has achieved some success,the situation is still serious,the man-agement of patients with initial treatment should be strengthened to reduce the occurrence of drug resistance.

关键词

结核分枝杆菌/肺结核/抗结核药物/耐药/耐多药/基线调查

Key words

Mycobacterium tuberculosis/pulmonary tuberculosis/anti-tuberculosis drug/drug resistance/multi-drug resistance/baseline survey

分类

医药卫生

引用本文复制引用

李于于,曾令城,柳巍..西安市结核分枝杆菌耐药基线调查[J].中国感染控制杂志,2016,15(12):952-955,4.

基金项目

西安市科技局项目[SF1208(5)] ()

中国感染控制杂志

OA北大核心CSTPCD

1671-9638

访问量0
|
下载量0
段落导航相关论文